January 2026 FDA New Drug Approvals Zycubo (copper histidinate) Some approvals mark progress. Others redefine what hope looks like. In January 2026, the U.S. FDA approved Zycubo (copper histidinate injection formerly The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn GHK Cu: The Peptide That Transforms Skin and Tissue Health Calibrate Hydration GHK Cu Peptide (50mg) Advanced Skin Rejuvenation & Healing Support